abdomino pelvic irradiation after second-look laparotomy for stage iii ovarian carcinoma:腹盆腔照射卵巢癌iii期后第二看剖腹探查术.pdf

abdomino pelvic irradiation after second-look laparotomy for stage iii ovarian carcinoma:腹盆腔照射卵巢癌iii期后第二看剖腹探查术.pdf

  1. 1、本文档共6页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
abdomino pelvic irradiation after second-look laparotomy for stage iii ovarian carcinoma:腹盆腔照射卵巢癌iii期后第二看剖腹探查术

European Journal of Obstetrics Gynecology E L S E V I E R and ReproductiveBiology62 (1995)43-48 Abdomino pelvic irradiation after second-look laparotomy for stage III ovarian carcinoma S o p h i e C h a p e t *a, C h r i s t i n e B e r g e r a, A l a i n F i g n o n b, Gilles Calais a, F r a n c k F e t i s s o f ¢, A g n e s R e y n a u d - B o u g n o u x a, P h i l i p p e D e s c a m p s c, Gilles B o d y c, J a c q u e s L a n s a c c, Olivier le F l o c h a aClinique dOncologie et Radiothirapie, Centre Hospitalier et Universitaire, 2 Bd Tonnell~, 37044 Tours, France bDdpartement de Gyndcologie et Obstdtrique, Centre Hospitalier et Universitaire, 2 Bd Tonnelli, 37044 Tours, France CLaboratoire ddnatomo - - Pathologie, Centre Hospitalier et Universitaire, 2 Bd Tonnelld, 37044 Tours, France Received26 December 1994;revisionreceived 6 February 1995;accepted 3 April 1995 Abstract Objective: The purpose of this retrospective analysis of 34 patients with stage III ovarian carcinoma was to review results and morbidity of whole abdominal irradiation after surgery and chemotherapy. Methods and materials: All of the 34 patients had reach- ed a complete clinical remission after first cytoreductive surgery and chemotherapy. After second-look laparotomy each patient underwent whole abdominal irradiation. Except for two patients with chronic myelosuppression, the dose administered was of 22.5 Gy to the abdominal cavity with a boost of 22.5 Gy added to the pelvis. Results: Three and 5-year overall survival rates were 62% and 43%, r

您可能关注的文档

文档评论(0)

ajgoaw + 关注
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档